Results 11 to 20 of about 2,698 (145)
Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life [PDF]
Гинекология, 2022 Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the ...
Mekan R. Orazov +5 more
doaj +1 more source
Complete labial fusion with urinary incontinence in a postmenopausal woman: A case report
Case Reports in Women's Health, 2022 An 83-year-old woman presented to a rural general hospital with urinary incontinence. She was diagnosed with complete labial fusion caused by genitourinary syndrome of menopause.
Rakan Kotoku, Yuji Orita
doaj +1 more source
Genitourinary Syndrome of Menopause Assessment Tools [PDF]
Journal of Mid-life Health, 2021 New therapeutic options are being considered to treat genitourinary syndrome of menopause (GSM), such as vaginal laser, ospemifene, or prasterone, but there is no explicit agreement in the scientific community for its use. Some concerns have arisen on how to evaluate the improvement of GSM symptoms.
Mension Coll, Eduard +8 more
openaire +3 more sources
Modern management of genitourinary syndrome of menopause [PDF]
Faculty Reviews, 2021 The genitourinary syndrome of menopause (GSM) is the accepted term used to describe the broad spectrum of genitourinary tract symptoms and signs caused by the loss of endogenous sex steroids that occurs at the time of and after the menopause. Global improvements in healthcare have resulted in an ageing population. Today, women are spending 40% of their
Da Silva, Ana Sofia +4 more
openaire +2 more sources
Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review
Гинекология, 2023 The real-world treatment of genitourinary syndrome of menopause has several limitations: contraindications to topical estrogen therapy, which is currently recognized as the "gold standard" treatment for vulvovaginal atrophy (VVA), fear of the systemic ...
Mekan R. Orazov +5 more
doaj +1 more source
BMC Women's Health, 2021 Background Genitourinary syndrome of menopause (GSM) involves vaginal dryness (VD), pain during sexual activity (SAPain), vaginal itching (VI), burning, pain, and symptoms in the urinary organs.
Cintia Pinheiro +7 more
doaj +1 more source
Modern approach to the management of genitourinary syndrome in women with gynecological malignancies
Radiology and Oncology, 2023 The term genitourinary syndrome of menopause was first used in 2014 by the North American Menopause Society and the International Society for the Study of Women's Sexual Health to describe conditions previously known as atrophic vaginitis, urogenital ...
Kovacevic Nina +3 more
doaj +1 more source
Акушерство, гинекология и репродукция, 2022 Surgical and natural menopause is often associated with depression symptoms. Along with the postpartum period, perimenopause is a “window of vulnerability” for depression development, because decline in estrogen level accounts for extinction of ...
D. V. Blinov +8 more
doaj +1 more source
Royal jelly for genitourinary syndrome of menopause: A randomized controlled trial
Gynecology and Obstetrics Clinical Medicine, 2021 Objective: Genitourinary syndrome of menopause is a progressive condition characterized by a decrease in estrogen, which causes bothersome genital symptoms. The purpose of the study was to determine the effect of royal jelly on the genitourinary syndrome
Vahid Mehrnoush, Fatemeh Darsareh
doaj +1 more source
Genitourinary syndrome of menopause: a modern approach to treatment
Гинекология, 2020 Life expectancy over the past half century has increased significantly and by 2025 approximately one in six people on Earth will be over 60 years old, thus, age-related diseases become even more relevant, this also applies to menopausal syndrome in ...
Madina I. Mazitova, Rezeda R. Mardieva
doaj +1 more source